# The HEARTFELT Study

Study · id `cardio:ct-nct06222099` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06222099](<https://clinicaltrials.gov/study/NCT06222099>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06222099

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.

## Technical summary

Registry record NCT06222099. Randomized; single masking; primary purpose prevention. Start 2025-10-23 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1500 participants (planned count; ClinicalTrials.gov record NCT06222099, source copy `cardio:ctgov-nct06222099-2026-11-16`, retrieved 2026-11-18)
- Started: 2025-10-23 (actual) (ClinicalTrials.gov record NCT06222099, source copy `cardio:ctgov-nct06222099-2026-11-16`, retrieved 2026-11-18)
- Primary completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT06222099, source copy `cardio:ctgov-nct06222099-2026-11-16`, retrieved 2026-11-18)
- Completion: 2030-12-31 (anticipated) (ClinicalTrials.gov record NCT06222099, source copy `cardio:ctgov-nct06222099-2026-11-16`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT06222099, source copy `cardio:ctgov-nct06222099-2026-11-16`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06222099-2026-11-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: The HEARTFELT Study
- Acronym: HEARTFELT
- Condition: Heart Failure
- Condition: Chronic Heart Failure
- Intervention (Device): Heartfelt Device installed
- Intervention (Other): Standard care
- Intervention (Device): Heartfelt-guided care
- Intervention (Other): Questionnaires
- Lead sponsor: Heartfelt Technologies
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Heartfelt Technologies (`cardio:org-heartfelt-technologies`)

## Provenance

Content hash: fe2f805f0b9c81da40ac6f0de0d00b756b4bfa4012ddaaf880e88022e9342e52
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
